openPR Logo
Press release

Anti-Depressant Drugs Market to 2027 - Global Analysis and Forecasts By Depression Disorder (Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder)

11-25-2019 09:53 AM CET | Health & Medicine

Press release from: Premium Market Insights

Premium Market Insights

Premium Market Insights

Anti-depressant drugs is a class of medications which is used to treat major depressive disorder, some anxiety disorders, some chronic pain conditions, and to help manage some addictions. Anti-depressant drugs also reduce symptoms of depressive disorders by correcting chemical imbalances of neurotransmitters in the brain. Chemical imbalances may be responsible for changes in mood and behavior.

Anti-depressant drugs market is anticipated to grow in the forecast period owing to driving factors such as growing prevalence of depression, rising geriatric population, and emergence of novel techniques for the development of drugs. Moreover, rising investments in R&D by the public and private sector, and increase in number of patent expiration of antidepressants are also offering opportunities in the market growth during the forecast period.

Top Companies Covered in this Report:
1. Alkermes Plc,, 2. Allergan Plc,, 3. Bristol Myers Squibb Co., 4. Eli Lilly and Co., 5. GlaxoSmithKline Plc, 6. H. Lundbeck, 7. Merck & Co., Inc., 8. Pfizer Inc., 9. Teva Pharmaceutical Industries Ltd., 10. Takeda Pharmaceutical Co. Ltd.

Get sample copy of “Anti-Depressant Drugs Market” at:

The "Global Anti-Depressant Drugs Market Analysis to 2027" is a specialized and in-depth study of the healthcare IT industry with a special focus on the global market trend analysis. The report aims to provide an overview of Anti-Depressant Drugs market with detailed market segmentation by service type, age group, and geography. The global Anti-Depressant Drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Anti-Depressant Drugs market players and offers key trends and opportunities in the market.

The global anti-depressant drugs market is segmented on the basis of product and depressive disorder. Based on product, the market is segmented as tricyclic antidepressants, selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, monoamine oxidase inhibitors, serotonin antagonist and reuptake inhibitors, and others. Based on depressive disorder, the market is segmented as major depressive disorder, obsessive-compulsive disorder, generalized anxiety disorder, panic disorder, and others.

The report analyzes factors affecting Anti-Depressant Drugs market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Anti-Depressant Drugs market in these regions.

Have any query? Enquire about report at:

Fundamentals of Table of Content:

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type       
1.5 Market by Application
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Anti-Depressant Drugs Market Size
2.2 Anti-Depressant Drugs Growth Trends by Regions
2.3 Industry Trends

3 Market Share by Key Players
3.1 Anti-Depressant Drugs Market Size by Manufacturers
3.2 Anti-Depressant Drugs Key Players Head office and Area Served
3.3 Key Players Anti-Depressant Drugs Product/Solution/Service
3.4 Date of Enter into Anti-Depressant Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Anti-Depressant Drugs Sales by Product
4.2 Global Anti-Depressant Drugs Revenue by Product
4.3 Anti-Depressant Drugs Price by Product

5 Breakdown Data by End User                                 
5.1 Overview
5.2 Global Anti-Depressant Drugs Breakdown Data by End User

Get Complete Report at:

Contact Us:                                          
Call: +912067274191

About Premiummarketinsights: is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anti-Depressant Drugs Market to 2027 - Global Analysis and Forecasts By Depression Disorder (Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder) here

News-ID: 1871716 • Views:

More Releases from Premium Market Insights

Noninvasive Traumatic Brain Injury Diagnostic Equipment Market Historical Analys …
The Noninvasive Traumatic Brain Injury Diagnostic Equipment Market size is expected to grow from US$ 1.349 billion in 2022 to US$ 3.541 billion by 2030. Factors such as the accelerated demand for advanced diagnostic equipment and quick and effective diagnosis for TBI patients propel the non-invasive traumatic brain injury diagnostic equipment market growth. However, the adverse effects of contrast medium/agent impede the growth of the market. Get Exclusive Sample PDF @: Analysis
Monoclonal Antibody Therapeutics (mABs) Market Growth Overview, Size, Future Tre …
The Monoclonal Antibody Therapeutics (mABs) Market size is expected to grow from US$ 192.043 billion in 2022 to US$ 542.801 billion by 2030; it is expected to grow at a CAGR of 13.9% from 2022 to 2030. Production of mABs-based drugs to treat several diseases are a few factors driving the monoclonal antibody therapeutics (mAbs) market growth. A monoclonal antibody (mAbs) drug is a homogenous collection of antibodies having specificity toward selected
Hyperpigmentation Disorder Treatment Market Comprehensive Analysis and Future Es …
The Hyperpigmentation Disorder Treatment Market size is expected to grow from US$ 6.68 billion in 2022 to US$ 11.78 billion by 2030; it is anticipated to record a CAGR of 7.4% from 2022 to 2030. Market Drivers of the Hyperpigmentation Disorder Treatment Market Rise in Prevalence of Melasma Melasma, one of the most dominant hyperpigmentation conditions, is characterized by symmetrical light to dark muddy-brown macules with borders on the face, particularly the chin,
Eye Allergy Treatment Market Size, Share and Trends Analysis Report by Type, By …
The Eye Allergy Treatment Market size is expected to grow from US$ 3.59 billion in 2022 to US$ 5.69 billion by 2030; it is projected to register a CAGR of 5.9% during 2022-2030. Eye allergy treatment includes products and solutions that are used to treat and manage allergies affecting the eyes. Treatment includes over-the-counter medications and prescription drugs used to improve symptoms such as redness, itching, tearing, and swelling of the

All 5 Releases

More Releases for Drugs

Global Antithrombotic Drugs Market | Global Antithrombotic Drugs Industry | Glob …
Antithrombotic drugs are special drugs that help to prevent the formation of thrombus or clot. These drugs are used to reduce the formation of blood clots by reducing the capability of body to form a blood clot. Antithrombotic drugs act by preventing the production of vitamin K in the liver. Anticoagulant, antiplatelet, and thrombolytic agents are different types of antithrombotic agents that act by different clotting processes. Arterial & venous
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication
Hepatitis Drugs Market by Therapeutics, Diagnostics, Patient, Drugs Policy
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market. Access Detailed Report Summary: Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest
Epilepsy Drugs Market by Country, Drugs, Company & Forecast
For More Information: Epilepsy is a chronic disease in which patient’s brain activities become abnormal due to seizures. Seizure is an unexpected rush of electrical activity in the brain. Seizure is categorized by two types - generalized seizures and focal or partial seizures. Generalized seizures affect the whole brain whereas focal or partial seizures affect just one part of the brain. Global epilepsy drugs market is expected to cross US$
Prospect of Global Excipients Market Research Report 2017 with Application inclu …
ResearchMoz added Latest Research Report titled " Global Excipients Market Research Report 2017 " to it's Large Report database. In this report, the global Excipients market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD),
Drugs research: Misuse by shareholders of the drugs industry
A new textbook illustrates the complex and multi-faceted dimensions of evidence building in European drugs research. On one level, the authors have identified practical and philosophical challenges regarding knowledge production including, for example, measurements of the drugs problem; researching the online world; and interpreting on-site drug tests. On another level, the authors have highlighted challenges regarding knowledge production such as the misuse of evidence by knowledge brokers and policymakers.